How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
Schwartz
Myron
M
Recanati-Miller Transplantation Institute, Mount Sinai School of Medicine, New York, USA. myron.schwartz@mssm.edu
Roayaie
Sasan
S
Llovet
Josep
J
D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology* / Q000601:surgery*; D016031:Liver Transplantation; D012008:Recurrence; D016019:Survival Analysis